SG11202105776WA - Imidazo[1,2-b]pyridazine il-17a inhibitors - Google Patents
Imidazo[1,2-b]pyridazine il-17a inhibitorsInfo
- Publication number
- SG11202105776WA SG11202105776WA SG11202105776WA SG11202105776WA SG11202105776WA SG 11202105776W A SG11202105776W A SG 11202105776WA SG 11202105776W A SG11202105776W A SG 11202105776WA SG 11202105776W A SG11202105776W A SG 11202105776WA SG 11202105776W A SG11202105776W A SG 11202105776WA
- Authority
- SG
- Singapore
- Prior art keywords
- imidazo
- pyridazine
- inhibitors
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D498/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D498/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
- C07D498/04—Ortho-condensed systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
- C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
- C07D487/04—Ortho-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/50—Pyridazines; Hydrogenated pyridazines
- A61K31/5025—Pyridazines; Hydrogenated pyridazines ortho- or peri-condensed with heterocyclic ring systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/06—Antipsoriatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07B—GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
- C07B2200/00—Indexing scheme relating to specific properties of organic compounds
- C07B2200/13—Crystalline forms, e.g. polymorphs
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- General Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Dermatology (AREA)
- Immunology (AREA)
- Epidemiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Peptides Or Proteins (AREA)
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US201962789247P | 2019-01-07 | 2019-01-07 | |
US201962842770P | 2019-05-03 | 2019-05-03 | |
PCT/US2020/012115 WO2020146194A1 (en) | 2019-01-07 | 2020-01-03 | Imidazo[1,2-b]pyridazine il-17a inhibitors |
Publications (1)
Publication Number | Publication Date |
---|---|
SG11202105776WA true SG11202105776WA (en) | 2021-06-29 |
Family
ID=69423406
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
SG11202105776WA SG11202105776WA (en) | 2019-01-07 | 2020-01-03 | Imidazo[1,2-b]pyridazine il-17a inhibitors |
Country Status (23)
Country | Link |
---|---|
US (1) | US20220073526A1 (zh) |
EP (1) | EP3908585B1 (zh) |
JP (1) | JP7291226B2 (zh) |
KR (1) | KR102600451B1 (zh) |
CN (1) | CN113286795B (zh) |
AU (1) | AU2020207196B2 (zh) |
BR (1) | BR112021011095B1 (zh) |
CA (1) | CA3125788C (zh) |
CL (1) | CL2021001720A1 (zh) |
CO (1) | CO2021008776A2 (zh) |
CR (1) | CR20210357A (zh) |
DO (1) | DOP2021000132A (zh) |
EC (1) | ECSP21050201A (zh) |
ES (1) | ES2977743T3 (zh) |
IL (1) | IL284228B2 (zh) |
JO (1) | JOP20210179A1 (zh) |
MA (1) | MA54696A (zh) |
MX (1) | MX2021008176A (zh) |
PE (1) | PE20212304A1 (zh) |
SA (1) | SA521422452B1 (zh) |
SG (1) | SG11202105776WA (zh) |
TW (2) | TW202214648A (zh) |
WO (1) | WO2020146194A1 (zh) |
Families Citing this family (25)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
MX2021006421A (es) | 2018-12-19 | 2021-08-16 | Leo Pharma As | Anilidas de aminoácidos como moduladores de moléculas pequeñas de interleucinas-17 (il-17). |
BR112022021962A2 (pt) | 2020-04-30 | 2023-03-28 | Janssen Pharmaceutica Nv | Imidazopiridazinas como moduladores de il-17 |
IL298887A (en) | 2020-06-12 | 2023-02-01 | Leo Pharma As | Small molecule modulators of IL-17 |
WO2021255174A1 (en) | 2020-06-18 | 2021-12-23 | Leo Pharma A/S | Small molecule modulators of il-17 |
WO2021255086A1 (en) | 2020-06-18 | 2021-12-23 | Leo Pharma A/S | Small molecule modulators of il-17 |
WO2021255085A1 (en) | 2020-06-18 | 2021-12-23 | Leo Pharma A/S | Small molecule modulators of il-17 |
EP3943495A1 (en) | 2020-07-24 | 2022-01-26 | Leo Pharma A/S | Small molecule modulators of il-17 |
CN113999234B (zh) * | 2020-07-28 | 2023-03-07 | 成都先导药物开发股份有限公司 | 一种免疫调节剂 |
US20230399328A1 (en) | 2020-11-09 | 2023-12-14 | UCB Biopharma SRL | Dicyclopropylmethyl derivatives as il-17 modulators |
WO2022096411A1 (en) | 2020-11-09 | 2022-05-12 | UCB Biopharma SRL | Dicyclopropylmethyl derivatives as il-17 modulators |
US20240140951A1 (en) | 2020-12-14 | 2024-05-02 | UCB Biopharma SRL | Imidazopyridazine derivatives as il-17 modulators |
AR126255A1 (es) | 2021-07-01 | 2023-10-04 | UCB Biopharma SRL | Derivados de imidazotriazina como moduladores de il-17 |
WO2023025783A1 (en) | 2021-08-23 | 2023-03-02 | Leo Pharma A/S | Small molecule modulators of il-17 |
AU2022348938A1 (en) * | 2021-09-27 | 2024-05-16 | Janssen Pharmaceutica Nv | Imidazopyridazine il-17 inhibitor compounds |
CA3233408A1 (en) * | 2021-09-27 | 2023-03-30 | Janssen Pharmaceutica Nv | Imidazopyridazine il-17 inhibitor compounds |
TW202413363A (zh) * | 2021-11-04 | 2024-04-01 | 大陸商西藏海思科製藥有限公司 | 一種可抑制il-17a之雜環化合物及其用途 |
WO2023111181A1 (en) | 2021-12-16 | 2023-06-22 | Leo Pharma A/S | Small molecule modulators of il-17 |
WO2023166172A1 (en) | 2022-03-04 | 2023-09-07 | Leo Pharma A/S | Small molecule modulators of il-17 |
CN114736104B (zh) * | 2022-04-20 | 2024-04-19 | 上海恩氟佳科技有限公司 | 一种二氟乙醛缩半乙醇的合成方法 |
WO2023225664A1 (en) * | 2022-05-19 | 2023-11-23 | Dice Alpha, Inc. | Lactam substituted imidazopyridazine il-17a modulators and uses thereof |
GB202210731D0 (en) | 2022-07-22 | 2022-09-07 | UCB Biopharma SRL | Therapeutic agents |
WO2024115662A1 (en) | 2022-12-02 | 2024-06-06 | Leo Pharma A/S | Small molecule modulators of il-17 |
WO2024138286A1 (en) * | 2022-12-26 | 2024-07-04 | Usynova Pharmaceuticals, Ltd. | Il-17a modulators |
WO2024163365A1 (en) * | 2023-01-30 | 2024-08-08 | Dice Alpha, Inc. | Benzimidazole and aza-benzimidazole based il-17a modulators and uses thereof |
WO2024173173A1 (en) * | 2023-02-13 | 2024-08-22 | Dice Alpha, Inc. | Imidazotriazine il-17a modulators and uses thereof |
Family Cites Families (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB9702213D0 (en) * | 1996-02-24 | 1997-03-26 | Zeneca Ltd | Chemical compounds |
WO2007013673A1 (en) | 2005-07-29 | 2007-02-01 | Astellas Pharma Inc. | Fused heterocycles as lck inhibitors |
WO2007104696A1 (en) * | 2006-03-15 | 2007-09-20 | Sigma-Tau Industrie Farmaceutiche Riunite S.P.A. | Antimalarial agents having polyaromatic structure |
JP5313909B2 (ja) * | 2006-11-13 | 2013-10-09 | アイコス コーポレイション | 炎症性疾患および癌の処置のためのチエノピリミジノン |
EP2892899B1 (en) * | 2012-09-06 | 2018-03-21 | Bristol-Myers Squibb Company | Imidazopyridazine jak3 inhibitors and their use for the treatment of inflammatory and autoimmune diseases |
WO2014066726A2 (en) | 2012-10-26 | 2014-05-01 | Ensemble Therapeutics Corporation | Compounds for modulating il-17 |
UA112028C2 (uk) * | 2012-12-14 | 2016-07-11 | Пфайзер Лімітед | Похідні імідазопіридазину як модулятори гамка-рецептора |
JP6458038B2 (ja) * | 2013-12-10 | 2019-01-23 | ブリストル−マイヤーズ スクイブ カンパニーBristol−Myers Squibb Company | IL−12、IL−23および/またはIFNα応答のモジュレーターとして有用なイミダゾピリダジン化合物 |
KR20180081584A (ko) * | 2015-11-18 | 2018-07-16 | 브리스톨-마이어스 스큅 컴퍼니 | Il-12, il-23 및/또는 ifn 알파 반응의 조정제로서 유용한 이미다조피리다진 화합물 |
-
2020
- 2020-01-02 TW TW111100669A patent/TW202214648A/zh unknown
- 2020-01-02 TW TW109100073A patent/TWI752400B/zh active
- 2020-01-03 CN CN202080008309.9A patent/CN113286795B/zh active Active
- 2020-01-03 MA MA054696A patent/MA54696A/fr unknown
- 2020-01-03 BR BR112021011095-0A patent/BR112021011095B1/pt active IP Right Grant
- 2020-01-03 CA CA3125788A patent/CA3125788C/en active Active
- 2020-01-03 JO JOP/2021/0179A patent/JOP20210179A1/ar unknown
- 2020-01-03 SG SG11202105776WA patent/SG11202105776WA/en unknown
- 2020-01-03 KR KR1020217020765A patent/KR102600451B1/ko active IP Right Grant
- 2020-01-03 CR CR20210357A patent/CR20210357A/es unknown
- 2020-01-03 MX MX2021008176A patent/MX2021008176A/es unknown
- 2020-01-03 ES ES20703322T patent/ES2977743T3/es active Active
- 2020-01-03 JP JP2021539549A patent/JP7291226B2/ja active Active
- 2020-01-03 WO PCT/US2020/012115 patent/WO2020146194A1/en unknown
- 2020-01-03 EP EP20703322.6A patent/EP3908585B1/en active Active
- 2020-01-03 PE PE2021001117A patent/PE20212304A1/es unknown
- 2020-01-03 IL IL284228A patent/IL284228B2/en unknown
- 2020-01-03 AU AU2020207196A patent/AU2020207196B2/en active Active
- 2020-01-03 US US17/419,997 patent/US20220073526A1/en active Pending
-
2021
- 2021-06-22 DO DO2021000132A patent/DOP2021000132A/es unknown
- 2021-06-25 CL CL2021001720A patent/CL2021001720A1/es unknown
- 2021-07-01 CO CONC2021/0008776A patent/CO2021008776A2/es unknown
- 2021-07-01 SA SA521422452A patent/SA521422452B1/ar unknown
- 2021-07-07 EC ECSENADI202150201A patent/ECSP21050201A/es unknown
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
IL284228A (en) | imidazo[1,2-b]pyridazine il-17a inhibitors | |
ZA201905456B (en) | Pyrrolo[1,2-b]pyridazine derivatives | |
IL276802B1 (en) | Transduced 2,1-dihydro-3h-pyrazolo[4,3-d]pyrimidine-3-ones | |
IL289462A (en) | Pyrazolo[4,3-b]pyrozine as shp2 phosphatase inhibitors | |
IL280513A (en) | Imidazo[2,1-B]pyridazines as TRK inhibitors | |
IL285311A (en) | Imidazo[1,2-f][4,2,1]triazine-4-amine derivatives as tlr7 agonists | |
ZA202100259B (en) | Pyrrolo[1,2-b]pyridazine derivatives | |
EP3956322A4 (en) | JAK1 SELECTIVE KINAS INHIBITOR | |
IL290445A (en) | [4,2,1]triazolo[5,1-c]quinazoline-5-amines | |
ZA202000875B (en) | Imidazo[1,5-a]pyrazine derivatives as pi3kdelta inhibitors | |
IL280122A (en) | Imidazo[2,1-B]pyridazine derivatives as TRK inhibitors | |
EP3475286A4 (en) | USE OF PYRROLO [2,3-D] PYRIDAZIN-4-ONES AND PYRAZOLO [3,4-D] PYRIDAZIN-4-ONES COMPOUNDS SUBSTITUTED AS INHIBITORS OF PROTEIN KINASES | |
IL279156A (en) | History of hexahydropyrrolo[4,3-C]pyrrole useful as LOX inhibitors |